Literature DB >> 15534619

Shared and specific susceptibility loci for schizophrenia and bipolar disorder: a dense genome scan in Eastern Quebec families.

M Maziade1, M-A Roy, Y C Chagnon, D Cliche, J-P Fournier, N Montgrain, C Dion, J-C Lavallée, Y Garneau, N Gingras, L Nicole, A Pirès, A-M Ponton, A Potvin, H Wallot, C Mérette.   

Abstract

The goal of this study was to identify susceptibility loci shared by schizophrenia (SZ) and bipolar disorder (BP), or specific to each. To this end, we performed a dense genome scan in a first sample of 21 multigenerational families of Eastern Quebec affected by SZ, BP or both (N=480 family members). This probably constitutes the first genome scan of SZ and BP that used the same ascertainment, statistical and molecular methods for the concurrent study of the two disorders. We genotyped 607 microsatellite markers of which 350 were spaced by 10 cM and 257 others were follow-up markers in positive regions at the 10 cM scan. Lander and Kruglyak thresholds were conservatively adjusted for multiple testings. We maximized the lod scores (mod score) over eight combinations (2 phenotype severity levels x 2 models of transmission x 2 analyses, affected/unaffected vs affected-only). We observed five genomewide significant linkages with mod score >4.0: three for BP (15q11.1, 16p12.3, 18q12-q21) and two for the shared phenotype, that is, the common locus (CL) phenotype (15q26,18q12-q21). Nine mod scores exceeded the suggestive threshold of 2.6: three for BP (3q21, 10p13, 12q23), three for SZ (6p22, 13q13, 18q21) and three for the CL phenotype (2q12.3, 13q14, 16p13). Mod scores >1.9 might represent confirmatory linkages of formerly reported genomewide significant findings such as our finding in 6p22.3 for SZ. Several regions appeared to be shared by SZ and BP. One linkage signal (15q26) appeared novel, whereas others overlapped formerly reported susceptibility regions. Despite the methodological limitations we raised, our data support the following trends: (i) results from several genome scans of SZ and BP in different populations tend to converge in specific genomic regions and (ii) some of these susceptibility regions may be shared by SZ and BP, whereas others may be specific to each. The present results support the relevance of investigating concurrently SZ and BP within the same study and have implications for the modelling of genetic effects.

Entities:  

Mesh:

Year:  2005        PMID: 15534619     DOI: 10.1038/sj.mp.4001594

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  43 in total

1.  Symptom dimensions as alternative phenotypes to address genetic heterogeneity in schizophrenia and bipolar disorder.

Authors:  Aurélie Labbe; Alexandre Bureau; Isabel Moreau; Marc-André Roy; Yvon Chagnon; Michel Maziade; Chantal Merette
Journal:  Eur J Hum Genet       Date:  2012-04-25       Impact factor: 4.246

2.  A linkage and family-based association analysis of a potential neurocognitive endophenotype of bipolar disorder.

Authors:  Jonathan Savitz; Lize van der Merwe; Mark Solms; Rajkumar Ramesar
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

3.  The right answer for the wrong reasons?

Authors:  Robin M Murray; Rina Dutta
Journal:  World Psychiatry       Date:  2007-06       Impact factor: 49.548

4.  Chromosome 13q13-q14 locus overlaps mood and psychotic disorders: the relevance for redefining phenotype.

Authors:  Michel Maziade; Yvon C Chagnon; Marc-André Roy; Alexandre Bureau; Alain Fournier; Chantal Mérette
Journal:  Eur J Hum Genet       Date:  2009-01-28       Impact factor: 4.246

5.  Cluster analysis of cognitive deficits may mark heterogeneity in schizophrenia in terms of outcome and response to treatment.

Authors:  Elsa Gilbert; Chantal Mérette; Valérie Jomphe; Claudia Emond; Nancie Rouleau; Roch-Hugo Bouchard; Marc-André Roy; Thomas Paccalet; Michel Maziade
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-10-31       Impact factor: 5.270

6.  Genome-wide searches for bipolar disorder genes.

Authors:  Shaza Alsabban; Margarita Rivera; Peter McGuffin
Journal:  Curr Psychiatry Rep       Date:  2011-12       Impact factor: 5.285

Review 7.  Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.

Authors:  Teodor T Postolache; Laura Del Bosque-Plata; Serge Jabbour; Michael Vergare; Rongling Wu; Claudia Gragnoli
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-02-06       Impact factor: 3.568

8.  Follow-up of a major psychosis linkage site in 13q13-q14 reveals significant association in both case-control and family samples.

Authors:  Alexandre Bureau; Yvon C Chagnon; Jordie Croteau; Alain Fournier; Marc-André Roy; Thomas Paccalet; Chantal Mérette; Michel Maziade
Journal:  Biol Psychiatry       Date:  2013-04-18       Impact factor: 13.382

9.  No evidence for association between 19 cholinergic genes and bipolar disorder.

Authors:  Jiajun Shi; Eiji Hattori; Hongwei Zou; Judith A Badner; Susan L Christian; Elliot S Gershon; Chunyu Liu
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-09-05       Impact factor: 3.568

10.  Association analysis of HSP90B1 with bipolar disorder.

Authors:  Chihiro Kakiuchi; Mizuho Ishiwata; Shinichiro Nanko; Hiroshi Kunugi; Yoshio Minabe; Kazuhiko Nakamura; Norio Mori; Kumiko Fujii; Tadashi Umekage; Mamoru Tochigi; Kazuhisa Kohda; Tsukasa Sasaki; Kazuo Yamada; Takeo Yoshikawa; Tadafumi Kato
Journal:  J Hum Genet       Date:  2007-09-04       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.